MetaCap

Insmed Statistics

NASDAQ: INSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

141.33-3.13 (-2.17%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Insmed by the numbers

Insmed has a market capitalization of $31.01 billion based on 219.38M shares outstanding. With trailing EPS of $-2.81, Insmed is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 27.2% above its 50-day average and 15.3% above its 200-day average.

Average daily trading volume is 3.09M shares, or about $436.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

INSM valuation vs. peer median

INSM compared with the median of 8 peer companies
MetricINSMPeer medianDifference
Market cap$31.01B$29.60B+5%
Forward P/E220.214.5+1417%
Avg. volume3.09M3.70M-17%

Peer median across 8 companies: GMAB, ZTS, ROIV, UTHR, RPRX, VTRS, ALNY, ONC.

Valuation

Market cap
$31.01B
Price / sales (latest FY)
51.13
EPS (TTM)
$-2.81

Price and trading

Previous close
144.46
Open
143.98
Day range
140.99 – 150.00
52-week range
90.39 – 212.75
52-week change
-28.89%
Beta
—
Volume
6.22M

Dividends and events

Annual dividend
None
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
31.01B
Forward Pe
220.18
Eps
-2.81
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
212.75
Week52 Low
90.39
Avg Volume
3.09M
Shares Outstanding
219.38M
Ma50
111.09
Ma200
122.56
Earnings Date
Oct 29, 2026
Pct From52w High
-33.57%
Pct From52w Low
56.36%

Related